Assessment of Chimpanzee Adenovirus Serotype 63 Neutralizing Antibodies Prior to Evaluation of a Candidate Malaria Vaccine Regimen Based on Viral Vectors

Prior to a chimpanzee adenovirus-based (ChAd63) malarial vaccine trial, sera were collected to assess ChAd63-specific neutralizing antibody titers in Banfora (Burkina Faso). The low neutralizing antibody titers reported in both adults and children (median titers, 139.1 and 35.0, respectively) are en...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nébié, Issa, Edwards, Nick J., Tiono, Alfred B., Ewer, Katie J., Sanou, Guillaume S., Soulama, Issiaka, Sanon, Souleymane, Diarra, Amidou, Yaro, Jean Baptiste, Kangoye, David, Imoukhuede, Egeruan B., Hill, Adrian V. S., Sirima, Sodiomon B.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2014
Matèries:
Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4054245/
https://ncbi.nlm.nih.gov/pubmed/24739980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00723-13
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars